Literature DB >> 20703457

Gastric tube reconstruction by laparoscopy-assisted surgery attenuates postoperative systemic inflammatory response after esophagectomy for esophageal cancer.

Hironori Tsujimoto1, Satoshi Ono, Hidekazu Sugasawa, Takashi Ichikura, Junji Yamamoto, Kazuo Hase.   

Abstract

BACKGROUND: Conventional open procedures have been supplanted in part by less invasive approaches, such as laparoscopic surgery developed for treating gastrointestinal malignancies. However, it is unclear whether laparoscopy-assisted gastric tube reconstruction (LAGT) can attenuate the postoperative systemic inflammatory response after esophagectomy for esophageal cancer.
METHODS: We investigated the postoperative clinical course of the systemic inflammatory response syndrome (SIRS) in patients who underwent an esophagectomy for esophageal cancer by LAGT (LAGT group) and gastric tube reconstruction by conventional open surgery (Open group).
RESULTS: Compared with the Open group, the LAGT group had a significantly shorter operative time (539.6 min vs. 639.8 min), shorter duration of postoperative mechanical ventilation (1.1 days vs. 2.8 days), and shorter length of stay in the intensive care unit (2.1 days vs. 4.4 days). The LAGT group also had a significantly shorter SIRS duration (1.4 days vs. 2.7 days), a significantly lower incidence of SIRS, and a smaller number of positive SIRS criteria. Throughout the investigation period, the postoperative white blood cell count was lower in the LAGT group than in the Open group. Additionally, in the LAGT group, the heart rate was lower on each postoperative day (POD), and the respiratory rate was significantly lower on postoperative days (PODs) 1 and 4. There was no difference in postoperative oxygenation, morbidity, and mortality between the groups. The C-reactive protein level on PODs 3 and 4 was significantly lower in the LAGT group than in the Open group.
CONCLUSIONS: Laparoscopy-assisted gastric tube reconstruction significantly attenuates postoperative SIRS, and it is therefore a potentially less invasive surgical procedure.

Entities:  

Mesh:

Year:  2010        PMID: 20703457     DOI: 10.1007/s00268-010-0757-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

2.  Activation of monocytes and endothelial cells depends on the severity of surgical stress.

Authors:  S Aosasa; S Ono; H Mochizuki; H Tsujimoto; S Osada; E Takayama; S Seki; H Hiraide
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

Review 3.  Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature.

Authors:  R J J Verhage; E J Hazebroek; J Boone; R Van Hillegersberg
Journal:  Minerva Chir       Date:  2009-04       Impact factor: 1.000

4.  A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report.

Authors:  Seigo Kitano; Norio Shiraishi; Kyuzo Fujii; Kazuhiro Yasuda; Masafumi Inomata; Yosuke Adachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

5.  Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response.

Authors:  Hironori Tsujimoto; Satoshi Ono; Kentaro Chochi; Hidekazu Sugasawa; Takashi Ichikura; Hidetaka Mochizuki
Journal:  Jpn J Clin Oncol       Date:  2006-10-04       Impact factor: 3.019

6.  Laparoscopic gastrectomy for early gastric cancer targeting as a less invasive procedure.

Authors:  Hideki Kawamura; Kuniaki Okada; Hiroyuki Isizu; Hiroyuki Masuko; Hideki Yamagami; Shigenori Honma; Shinya Ueki; Keita Noguchi; Yukifumi Kondo
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

7.  Prediction of pulmonary complications after transthoracic oesophagectomy.

Authors:  H Nagawa; O Kobori; T Muto
Journal:  Br J Surg       Date:  1994-06       Impact factor: 6.939

8.  Interleukin-18 concentration in the peritoneal fluid correlates with the severity of peritonitis.

Authors:  Shin-ichi Ikuta; Satoshi Ono; Manabu Kinoshita; Hironori Tsujimoto; Akira Yamauchi; Hidetaka Mochizuki
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

9.  Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.

Authors:  Hironori Tsujimoto; Satoshi Ono; Takashi Majima; Philip A Efron; Manabu Kinoshita; Hoshio Hiraide; Lyle L Moldawer; Hidetaka Mochizuki
Journal:  Clin Immunol       Date:  2006-03-06       Impact factor: 3.969

10.  Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.

Authors:  R A Pixley; S Zellis; P Bankes; R A DeLa Cadena; J D Page; C F Scott; J Kappelmayer; E G Wyshock; J J Kelly; R W Colman
Journal:  Crit Care Med       Date:  1995-01       Impact factor: 7.598

View more
  8 in total

1.  Laparoscopic jejunostomy for obstructing upper gastrointestinal malignancies.

Authors:  Hironori Tsujimoto; Shuichi Hiraki; Risa Takahata; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Hiroyuki Horiguchi; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Journal:  Mol Clin Oncol       Date:  2015-07-30

2.  Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer.

Authors:  Yusuke Ishibashi; Hironori Tsujimoto; Keita Kouzu; Yujiro Itazaki; Satoshi Tsuchiya; Seiichiro Fujishima; Yoshihisa Yaguchi; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Hiromi Nagata; Eiji Shinto; Yoji Kishi; Hideki Ueno
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Low invasiveness of thoracoscopic esophagectomy in the prone position for esophageal cancer: a propensity score-matched comparison of operative approaches between thoracoscopic and open esophagectomy.

Authors:  Shinsuke Kanekiyo; Shigeru Takeda; Masahito Tsutsui; Mitsuo Nishiyama; Masahiro Kitahara; Yoshitaro Shindo; Yukio Tokumitsu; Shinobu Tomochika; Yoshihiro Tokuhisa; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Yamamoto; Shigefumi Yoshino; Shoichi Hazama; Tomio Ueno; Hiroaki Nagano
Journal:  Surg Endosc       Date:  2017-10-26       Impact factor: 4.584

4.  Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis.

Authors:  Can Zhou; Li Zhang; Hua Wang; Xiaoxia Ma; Bohui Shi; Wuke Chen; Jianjun He; Ke Wang; Peijun Liu; Yu Ren
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

5.  C-reactive protein as predictor of anastomotic complications after minimally invasive oesophagectomy.

Authors:  Vladimir Prochazka; Filip Marek; Lumir Kunovsky; Roman Svaton; Martina Farkasova; Martin Potrusil; Petr Moravcik; Zdenek Kala
Journal:  J Minim Access Surg       Date:  2019 Jan-Mar       Impact factor: 1.407

Review 6.  Is minimally invasive esophagectomy effective for preventing anastomotic leakages after esophagectomy for cancer? A systematic review and meta-analysis.

Authors:  Can Zhou; Gang Ma; Xiao Li; Juan Li; Yu Yan; Peijun Liu; Jianjun He; Yu Ren
Journal:  World J Surg Oncol       Date:  2015-09-04       Impact factor: 2.754

7.  Comparison of thoracolaparoscopic esophagectomy with cervical anastomosis with McKeown esophagectomy for middle esophageal cancer.

Authors:  Hai-Tao Huang; Fei Wang; Liang Shen; Chun-Qiu Xia; Chen-Xi Lu; Chong-Jun Zhong
Journal:  World J Surg Oncol       Date:  2015-11-05       Impact factor: 2.754

8.  Predictive value of immuno-inflammatory and nutritional measures modulated by neoadjuvant chemotherapy on the response of neoadjuvant chemotherapy and long-term outcomes in patients with esophageal cancer.

Authors:  Yusuke Ishibashi; Hironori Tsujimoto; Shuichi Hiraki; Keita Kouzu; Satoshi Tsuchiya; Yujiro Itazaki; Yoshihisa Yaguchi; Hiroyuki Horiguchi; Shinsuke Nomura; Nozomi Ito; Eiji Shinto; Yoji Kishi; Hideki Ueno
Journal:  Oncol Lett       Date:  2019-11-19       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.